BR8007911A
(pt)
|
1979-12-06 |
1981-06-16 |
Glaxo Group Ltd |
Inalador aperfeicoado
|
SE430885B
(sv)
|
1980-03-24 |
1983-12-19 |
Ferring Ab |
Oxytocin-derivat
|
CA1224992A
(en)
|
1982-10-08 |
1987-08-04 |
Robert E. Newell |
Device for administering medicament to patients
|
IL79550A
(en)
|
1985-07-30 |
1991-06-10 |
Glaxo Group Ltd |
Devices for administering medicaments to patients
|
ES2061591T3
(es)
|
1987-10-15 |
1994-12-16 |
Syntex Inc |
Administracion intranasal de polipeptidos en forma pulverizada.
|
EP0360340A1
(en)
|
1988-09-19 |
1990-03-28 |
Akzo N.V. |
Composition for nasal administration containing a peptide
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
JPH05963A
(ja)
|
1990-04-13 |
1993-01-08 |
Toray Ind Inc |
ポリペプチド類組成物
|
JPH05507090A
(ja)
|
1990-05-08 |
1993-10-14 |
リポサーム テクノロジー インコーポレイテッド |
直接噴霧乾燥された薬剤/脂質粉末組成物
|
MX9201782A
(es)
|
1991-04-19 |
1992-10-01 |
Sandoz Ag |
Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
|
KR100246082B1
(ko)
|
1991-07-02 |
2000-04-01 |
인헤일, 인코오포레이티드 |
에어로졸화된약제를전달하는방법및장치
|
AU659328B2
(en)
|
1992-06-12 |
1995-05-11 |
Teijin Limited |
Ultrafine powder for inhalation and production thereof
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
JPH08509465A
(ja)
|
1993-01-29 |
1996-10-08 |
マイリス メディカル コーポレーション |
ホルモンの肺内送達
|
US5558085A
(en)
|
1993-01-29 |
1996-09-24 |
Aradigm Corporation |
Intrapulmonary delivery of peptide drugs
|
US6012450A
(en)
|
1993-01-29 |
2000-01-11 |
Aradigm Corporation |
Intrapulmonary delivery of hematopoietic drug
|
WO1994021229A1
(en)
|
1993-03-17 |
1994-09-29 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
HU220472B1
(hu)
|
1994-09-21 |
2002-02-28 |
Inhale Therapeutic Systems |
Eljárás és készülék por aeroszolosítására, valamint a készülékben alkalmazott adagolócső-egység
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
SE9404468D0
(sv)
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
CA2216443A1
(en)
|
1995-03-31 |
1996-10-03 |
Aradigm Corporation |
Intrapulmonary delivery of hematopoietic drug
|
CZ292578B6
(cs)
|
1995-04-14 |
2003-10-15 |
Glaxo Wellcome Inc. |
Inhalátor, inhalační systém
|
EP0820277B1
(en)
|
1995-04-14 |
2005-01-26 |
Nektar Therapeutics |
Powdered pharmaceutical formulations having improved dispersibility
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US5780014A
(en)
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
GB9606188D0
(en)
|
1996-03-23 |
1996-05-29 |
Danbiosyst Uk |
Pollysaccharide microspheres for the pulmonary delivery of drugs
|
GB9606677D0
(en)
|
1996-03-29 |
1996-06-05 |
Glaxo Wellcome Inc |
Process and device
|
HUP9901575A3
(en)
|
1996-04-29 |
1999-11-29 |
Dura Pharmaceuticals Inc San D |
Methods of dry powder inhalation
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
CA2263765C
(en)
|
1996-08-19 |
2010-03-30 |
Vivorx Pharmaceuticals, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
JP3020141B2
(ja)
|
1996-10-07 |
2000-03-15 |
株式会社富士薬品 |
経鼻投与用製剤
|
US5976574A
(en)
|
1996-12-31 |
1999-11-02 |
Inhale Therapeutic Systems |
Processes for spray drying hydrophobic drugs in organic solvent suspensions
|
ZA9711732B
(en)
|
1996-12-31 |
1998-12-28 |
Quadrant Holdings Cambridge |
Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
HU226671B1
(en)
|
1997-03-20 |
2009-06-29 |
Schering Corp |
Preparation of powder agglomerates
|
EP0876814A1
(en)
|
1997-05-07 |
1998-11-11 |
"PHARLYSE", Société Anonyme |
Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
|
TW533865U
(en)
|
1997-06-10 |
2003-05-21 |
Glaxo Group Ltd |
Dispenser for dispensing medicament and actuation indicating device
|
AUPO871997A0
(en)
|
1997-08-25 |
1997-09-18 |
Csl Limited |
Dried biologically or therapeutically active preparations
|
WO1999016420A1
(en)
|
1997-09-29 |
1999-04-08 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in nebulizers
|
ATE238035T1
(de)
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
Perforierte mikropartikel und deren verwendung
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
AU1307399A
(en)
|
1997-11-06 |
1999-05-31 |
Orbon Corporation |
Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
|
GB9727102D0
(en)
|
1997-12-22 |
1998-02-25 |
Andaris Ltd |
Microparticles and their therapeutic use
|
US5902844A
(en)
|
1998-02-02 |
1999-05-11 |
Applied Analytical Industries, Inc. |
Spray drying of pharmaceutical formulations containing amino acid-based materials
|
EE200000546A
(et)
|
1998-03-16 |
2002-02-15 |
Inhale Therapeutic Systems, Inc. |
Aerosoolistatud toimeaine manustamissüsteem
|
DK1107743T3
(da)
|
1998-08-25 |
2007-10-22 |
Advanced Inhalation Res Inc |
Stabile, spraytörrede proteinformuleringer
|
MA25590A1
(fr)
|
1998-09-14 |
2002-12-31 |
Inhale Therapeutic Syst |
Agent actif de delivraison de poudre seche
|
AU756852B2
(en)
|
1998-11-13 |
2003-01-23 |
Jagotec Ag |
Dry powder for inhalation
|
GB9827145D0
(en)
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
US6390291B1
(en)
|
1998-12-18 |
2002-05-21 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6315112B1
(en)
|
1998-12-18 |
2001-11-13 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6352152B1
(en)
|
1998-12-18 |
2002-03-05 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6119853A
(en)
|
1998-12-18 |
2000-09-19 |
Glaxo Wellcome Inc. |
Method and package for storing a pressurized container containing a drug
|
US6447806B1
(en)
|
1999-02-25 |
2002-09-10 |
Novartis Ag |
Pharmaceutical compositions comprised of stabilized peptide particles
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6453758B1
(en)
|
1999-06-11 |
2002-09-24 |
Msp Corporation |
Efficient high-productivity cascade impactors
|
GB9915975D0
(en)
|
1999-07-07 |
1999-09-08 |
Bradford Particle Design Ltd |
Method for the formation of particles
|
US7252840B1
(en)
|
1999-08-25 |
2007-08-07 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles
|
US20010036481A1
(en)
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
AU763041B2
(en)
|
1999-08-25 |
2003-07-10 |
Alkermes, Inc. |
Modulation of release from dry powder formulations
|
EP1210069B1
(en)
|
1999-08-25 |
2004-12-29 |
Advanced Inhalation Research, Inc. |
Large porous particles obtainable by spray-drying and suitable for pulmonary administration
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
CA2383798A1
(en)
|
1999-09-07 |
2001-03-15 |
Conjuchem Inc. |
Pulmonary delivery for bioconjugation
|
US6706892B1
(en)
|
1999-09-07 |
2004-03-16 |
Conjuchem, Inc. |
Pulmonary delivery for bioconjugation
|
WO2001051030A1
(en)
|
2000-01-10 |
2001-07-19 |
Dura Pharmaceuticals, Inc. |
Pharmaceutical formulation and method for pulmonary and oral delivery
|
GB0003935D0
(en)
|
2000-02-08 |
2000-04-12 |
King S College London |
Formulation for dry powder inhaler
|
EP1129705A1
(en)
|
2000-02-17 |
2001-09-05 |
Rijksuniversiteit te Groningen |
Powder formulation for inhalation
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
EP1276474B1
(en)
|
2000-04-17 |
2007-06-13 |
Vectura Limited |
Formulations for use in inhaler devices
|
GB0010709D0
(en)
|
2000-05-03 |
2000-06-28 |
Vectura Ltd |
Powders for use a in dry powder inhaler
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
AU2001264789A1
(en)
|
2000-06-08 |
2001-12-17 |
Eli Lilly And Company |
Protein powder for pulmonary delivery
|
ATE378039T1
(de)
|
2000-06-27 |
2007-11-15 |
Vectura Ltd |
Herstellungsverfahren für partikel zur verwendung in einer arzneizusammensetzung
|
SE516555C2
(sv)
|
2000-08-04 |
2002-01-29 |
Microdrug Ag |
Elektropulver
|
GB0020616D0
(en)
|
2000-08-21 |
2000-10-11 |
Quadrant Holdings Cambridge |
Particulates
|
SE516554C2
(sv)
|
2000-08-31 |
2002-01-29 |
Microdrug Ag |
Uppmätt elektrodos
|
DE10043509A1
(de)
|
2000-09-01 |
2002-03-14 |
Asta Medica Ag |
Feste Peptidzubereitungen für die Inhalation und deren Herstellung
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
CA2429665C
(en)
|
2000-11-30 |
2013-10-22 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
EP2283818B1
(en)
|
2000-11-30 |
2017-08-02 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US8580306B2
(en)
|
2000-11-30 |
2013-11-12 |
Vectura Limited |
Particles for use in a pharmaceutical composition
|
AUPR197000A0
(en)
|
2000-12-08 |
2001-01-11 |
Unisearch Limited |
Synthesis of small particles
|
US6543301B2
(en)
|
2000-12-08 |
2003-04-08 |
Msp Corporation |
Impactor nozzle plate
|
US6595368B2
(en)
|
2000-12-08 |
2003-07-22 |
Msp Corporation |
Pre-separator for inlets of cascade impactors
|
CA2432175C
(en)
|
2000-12-21 |
2010-08-10 |
Jayne E. Hastedt |
Storage stable powder compositions of interleukin-4 receptor
|
CA2433335C
(en)
|
2000-12-29 |
2010-04-20 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having sustained release properties
|
DE60221640T2
(de)
|
2001-02-06 |
2008-05-21 |
Innovata Biomed Ltd., St. Albans |
Bimodale trockenpulverzusammensetzung zur inhalation
|
US6475468B2
(en)
|
2001-02-15 |
2002-11-05 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
GB0107106D0
(en)
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
EG24184A
(en)
|
2001-06-15 |
2008-10-08 |
Otsuka Pharma Co Ltd |
Dry powder inhalation system for transpulmonary
|
US20030035774A1
(en)
|
2001-07-18 |
2003-02-20 |
Adjei Akwete L. |
Salt/ion pair medicinal aerosol formulation
|
WO2003015750A1
(en)
|
2001-08-16 |
2003-02-27 |
Baxter International, Inc. |
Propellant-based microparticle formulations
|
JP2005507881A
(ja)
|
2001-09-17 |
2005-03-24 |
グラクソ グループ リミテッド |
乾燥粉末医薬製剤
|
ITMI20012174A1
(it)
|
2001-10-18 |
2003-04-18 |
Univ Parma |
Polvere per somministrazione nasale di farmaci
|
AU2002335046A1
(en)
|
2001-10-19 |
2003-05-06 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
ATE401058T1
(de)
|
2001-11-01 |
2008-08-15 |
Nektar Therapeutics |
Sprühtrocknungsverfahren
|
US20030166509A1
(en)
|
2001-11-20 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Compositions for sustained action product delivery and methods of use thereof
|
JP4368198B2
(ja)
|
2001-11-20 |
2009-11-18 |
アルカーメス,インコーポレイテッド |
肺送達用の改良された粒状組成物
|
FR2834636B1
(fr)
|
2002-01-15 |
2006-02-24 |
El Hassane Larhrib |
Procede de fabrication de particules micro-poreuses creuses, notamment destinees a etre inhalees
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
BR0306741A
(pt)
|
2002-02-22 |
2004-12-28 |
Ajinomoto Kk |
Método para produzir um pó de aminoácidos, e, pó de aminoácidos
|
AU2003215334A1
(en)
|
2002-02-22 |
2003-09-09 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
AU2002316574B2
(en)
|
2002-03-15 |
2008-05-01 |
Brandeis University |
Central airway administration for systemic delivery of therapeutics
|
US20040009231A1
(en)
|
2002-03-20 |
2004-01-15 |
Advanced Inhalation Research, Inc. |
hGH (human growth hormone) formulations for pulmonary administration
|
US20040042972A1
(en)
|
2002-04-11 |
2004-03-04 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
WO2003086358A1
(en)
|
2002-04-12 |
2003-10-23 |
Campina Nederland Holding B.V. |
Excipient for use in dry powder inhalation preparations
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
JP2006513139A
(ja)
|
2002-07-03 |
2006-04-20 |
ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド |
治療薬の全身性送達のための中央部気道投与
|
AU2003279070A1
(en)
|
2002-09-30 |
2004-04-23 |
Acusphere Inc |
Sustained release porous microparticles for inhalation
|
CA2508592A1
(en)
|
2002-12-17 |
2004-07-15 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
GB0300427D0
(en)
|
2003-01-09 |
2003-02-05 |
Univ Strathclyde |
Pharmaceutical composition
|
US20040184995A1
(en)
|
2003-03-17 |
2004-09-23 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
|
EP1603615B1
(en)
|
2003-03-20 |
2008-07-09 |
Galephar M/F |
Improved dry powder inhaler system
|
AU2004280158B2
(en)
|
2003-07-18 |
2011-02-17 |
Baxter International, Inc. |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
GB0317374D0
(en)
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
DE10339197A1
(de)
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
WO2005044187A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
WO2005044186A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
DE10358387A1
(de)
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
US20050191246A1
(en)
|
2003-12-13 |
2005-09-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powders comprising low molecular dextran and methods of producing those powders
|
DE102004002926A1
(de)
|
2004-01-20 |
2005-08-18 |
Living Byte Software Gmbh |
USB-Vorrichtung
|
EP1718277A1
(en)
|
2004-02-10 |
2006-11-08 |
Advanced Inhalation Research, Inc. |
Particles for inhalation rapid release properties
|
EP1713441A2
(en)
|
2004-02-12 |
2006-10-25 |
Nektar Therapeutics |
Interleukin-13 antagonist powders, spray-dried particles, and methods
|
US20050207983A1
(en)
|
2004-03-05 |
2005-09-22 |
Pulmatrix, Inc. |
Formulations decreasing particle exhalation
|
SE528121C2
(sv)
|
2004-03-29 |
2006-09-05 |
Mederio Ag |
Preparering av torrpulver för på förhand uppmätt DPI
|
PL1737304T3
(pl)
|
2004-04-09 |
2014-10-31 |
Nutricia Nv |
Zagęszczona płynna formuła
|
DE102004022926A1
(de)
|
2004-05-10 |
2005-12-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung
|
DE102004022928A1
(de)
|
2004-05-10 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung
|
GB0416328D0
(en)
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
SE0402345L
(sv)
|
2004-09-24 |
2006-03-25 |
Mederio Ag |
Uppmätt läkemedelsdos
|
WO2006055950A1
(en)
|
2004-11-18 |
2006-05-26 |
Nektar Therapeutics |
Pharmaceutical dry powder formulation on the basis particles comprising multiple active agents
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
WO2007120644A2
(en)
|
2006-04-12 |
2007-10-25 |
Pulmatrix, Inc. |
Diagnostic device for determining particle production
|
AU2006205108B2
(en)
|
2005-01-10 |
2013-01-10 |
Pulmatrix, Inc. |
Method and device for decreasing contamination
|
CN101247898B
(zh)
|
2005-05-05 |
2011-01-26 |
普马特里克斯公司 |
超音波气雾产生器
|
EP2402001A1
(en)
|
2005-05-18 |
2012-01-04 |
Pulmatrix, Inc. |
Formulations for alteration of biophysical properties of mucosal lining
|
US7694357B2
(en)
|
2005-07-06 |
2010-04-13 |
Joanne Alvite |
Safety bar for a bathtub
|
US20090220435A1
(en)
|
2005-07-27 |
2009-09-03 |
Nastech Pharmaceutical Company Inc. |
Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
JP4878463B2
(ja)
|
2005-09-13 |
2012-02-15 |
ホソカワミクロン株式会社 |
ペプチドホルモン封入ナノ粒子を含む医薬製剤及びその製造方法
|
GB0520794D0
(en)
|
2005-10-12 |
2005-11-23 |
Innovata Biomed Ltd |
Inhaler
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
GB0525254D0
(en)
|
2005-12-12 |
2006-01-18 |
Jagotec Ag |
Powder compositions for inhalation
|
US20100226990A1
(en)
|
2006-01-27 |
2010-09-09 |
The Provost, Fellows And Scholars Of The College O |
Method of Producing Porous Microparticles
|
WO2007095288A2
(en)
|
2006-02-13 |
2007-08-23 |
Nektar Therapeutics |
Methionine-containing protein or peptide compositions and methods of making and using
|
EP1986679B1
(en)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
FR2902007B1
(fr)
|
2006-06-09 |
2012-01-13 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques
|
US8679540B2
(en)
|
2006-06-09 |
2014-03-25 |
Flamel Technologies |
Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
|
DE102006030164A1
(de)
|
2006-06-29 |
2008-01-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Pulver
|
WO2008013955A2
(en)
|
2006-07-27 |
2008-01-31 |
Nektar Therapeutics |
Sustained release formulations for pulmonary delivery
|
FR2904219B1
(fr)
|
2006-07-28 |
2010-08-13 |
Flamel Tech Sa |
Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant
|
US20080102128A1
(en)
|
2006-07-28 |
2008-05-01 |
Flamel Technologies, Inc. |
Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
|
CN101500937A
(zh)
|
2006-08-11 |
2009-08-05 |
万能药生物有限公司 |
用于递送活性成分的粒子及其制备方法和组合物
|
JP5623743B2
(ja)
*
|
2006-10-20 |
2014-11-12 |
アムジエン・インコーポレーテツド |
安定なポリペプチド製剤
|
GB0622818D0
(en)
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
CA2716159A1
(en)
|
2007-06-01 |
2008-12-04 |
Novo Nordisk A/S |
Stable non-aqueous pharmaceutical compositions
|
US8614255B2
(en)
|
2007-08-21 |
2013-12-24 |
Civitas Therapeutics, Inc. |
Pulmonary pharmaceutical formulations
|
WO2009033701A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of urodilatin as a therapeutic agent
|
CN101888831A
(zh)
|
2007-10-05 |
2010-11-17 |
哈佛大学的校长及成员们 |
细胞材料的干粉
|
EP2050437A1
(en)
|
2007-10-15 |
2009-04-22 |
Laboratoires SMB |
Improved pharmaceutical dry powder compositions for inhalation.
|
CN101317821B
(zh)
|
2007-11-15 |
2012-01-04 |
陈晓东 |
适用于肺部给药的超细干粉颗粒及其制备方法
|
WO2009090189A1
(en)
|
2008-01-15 |
2009-07-23 |
Abbott Gmbh & Co.Kg |
Powdered protein compositions and methods of making same
|
GB0801876D0
(en)
|
2008-02-01 |
2008-03-12 |
Vectura Group Plc |
Suspension formulations
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US8714435B2
(en)
|
2008-04-30 |
2014-05-06 |
Lincoln Global, Inc. |
Collapsible carton
|
WO2009143011A1
(en)
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP2161030A1
(en)
|
2008-09-09 |
2010-03-10 |
Rijksuniversiteit te Groningen |
Oxytocin formulations and uses thereof
|
EP2344200A2
(en)
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modified therapeutics peptides, methods of their preparation and use
|
CN106880596A
(zh)
*
|
2008-10-15 |
2017-06-23 |
精达制药公司 |
高浓缩药物颗粒、制剂、混悬剂及其应用
|
US20100183876A1
(en)
|
2008-12-23 |
2010-07-22 |
Hell Andre |
Process for the Preparation of a Peptide Powder Form
|
CN102438602B
(zh)
|
2009-03-04 |
2016-04-13 |
曼金德公司 |
改进的干燥粉末药物输送系统
|
RS52239B
(en)
|
2009-03-26 |
2012-10-31 |
Pulmatrix, Inc. |
PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATMENT OF RESPIRATORY TRACT INFECTIONS
|
AU2010229730A1
(en)
|
2009-03-26 |
2011-10-06 |
Pulmatrix, Inc. |
Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
|
EP2410985A2
(en)
|
2009-03-26 |
2012-02-01 |
Pulmatrix, Inc. |
Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
|
US20120070417A1
(en)
|
2009-03-26 |
2012-03-22 |
Pulmatrix, Inc. |
Anti-influenza formulations and methods
|
EP2410981B2
(en)
|
2009-03-26 |
2020-02-26 |
Pulmatrix Operating Company, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
WO2010124198A2
(en)
|
2009-04-24 |
2010-10-28 |
Schering Corporation |
Agglomerate formulations useful in dry powder inhalers
|
GB0908129D0
(en)
|
2009-05-12 |
2009-06-24 |
Innovata Ltd |
Composition
|
WO2010132827A1
(en)
|
2009-05-15 |
2010-11-18 |
Bend Research, Inc. |
Low-molecular dextran for powder inhalations
|
US20100310660A1
(en)
|
2009-06-08 |
2010-12-09 |
Taipei Medical University |
Dry powder microparticles for pulmonary delivery
|
TWI463990B
(zh)
|
2009-09-21 |
2014-12-11 |
Ferring Bv |
催產素受體促進劑
|
GB0918450D0
(en)
|
2009-10-21 |
2009-12-09 |
Innovata Ltd |
Composition
|
US9433588B2
(en)
|
2009-11-09 |
2016-09-06 |
Virginia Commonwealth Univeristy |
Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
|
JP5793179B2
(ja)
|
2010-03-22 |
2015-10-14 |
バイオ−シネクティクス インク.Bio−Synectics Inc. |
ナノ粒子の製造方法
|
WO2011120779A1
(en)
|
2010-04-01 |
2011-10-06 |
Chiesi Farmaceutici S.P.A. |
Process for preparing carrier particles for dry powders for inhalation
|
MX359281B
(es)
|
2010-06-21 |
2018-09-21 |
Mannkind Corp |
Sistema y metodos para suministrar un farmaco en polvo seco.
|
US20130203715A1
(en)
|
2010-07-20 |
2013-08-08 |
Pulmatrix, Inc. |
Use of trp channel agonists to treat infections
|
CA2713560C
(en)
|
2010-08-23 |
2019-10-29 |
Jangofish Holdings Inc. |
Process and method for producing foamable metals
|
WO2012030664A1
(en)
|
2010-08-30 |
2012-03-08 |
Pulmatrix, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
US8758824B2
(en)
|
2010-08-30 |
2014-06-24 |
Pulmatrix, Inc. |
Respirably dry powder comprising calcium lactate, sodium chloride and leucine
|
WO2012028745A1
(en)
|
2010-09-03 |
2012-03-08 |
Pharmaterials Limited |
Pharmaceutical composition suitable for use in a dry powder inhaler
|
CN107096014B
(zh)
|
2010-09-29 |
2022-07-15 |
普马特里克斯营业公司 |
吸入用单价金属阳离子干粉剂
|
ES2710537T3
(es)
|
2010-09-29 |
2019-04-25 |
Pulmatrix Operating Co Inc |
Polvos secos catiónicos
|
JP2014504260A
(ja)
|
2010-10-15 |
2014-02-20 |
グラクソ グループ リミテッド |
集合ナノ粒子状薬物製剤、その製造及び使用
|
JOP20120023B1
(ar)
|
2011-02-04 |
2022-03-14 |
Novartis Ag |
صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
|
CN102228678A
(zh)
|
2011-06-22 |
2011-11-02 |
深圳翰宇药业股份有限公司 |
一种卡贝缩宫素药物组合物及其制备方法
|
PT2739268T
(pt)
*
|
2011-08-01 |
2019-01-28 |
Univ Monash |
Método e formulação para inalação
|
JP6101268B2
(ja)
|
2011-08-26 |
2017-03-22 |
カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ |
色素が捕捉されたゾルゲルフィルムに基づく亜硝酸塩テストストリップセンサ、及び、該ストリップセンサを調製するためのプロセス
|
MC200149A1
(fr)
|
2011-09-02 |
2012-09-26 |
Florent Saez |
Generateur bionique hybride universel
|
US20140336159A1
(en)
|
2011-10-07 |
2014-11-13 |
Pulmatrix, Inc. |
Methods for treating and diagnosing respiratory tract infections
|
US9474715B2
(en)
|
2011-11-30 |
2016-10-25 |
Andreas Voigt |
Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
|
WO2013113767A1
(en)
|
2012-01-31 |
2013-08-08 |
Bioclin Bv |
Method for administration of a probiotic
|
NZ629438A
(en)
|
2012-02-28 |
2016-10-28 |
Iceutica Holdings Inc |
Inhalable pharmaceutical compositions
|
CN104487075A
(zh)
|
2012-02-29 |
2015-04-01 |
普马特里克斯公司 |
可吸入干粉剂
|
US8753643B1
(en)
|
2012-04-11 |
2014-06-17 |
Life-Science Innovations, Llc |
Spray dried compositions and methods of use
|
WO2014078258A1
(en)
|
2012-11-16 |
2014-05-22 |
Merck Sharp & Dohme Corp. |
Process for making agglomerates using acoustic mixing technology
|
CN103110611A
(zh)
|
2012-12-11 |
2013-05-22 |
苏州惠仁生物科技有限公司 |
吸入剂及其制备方法与普鲁兰糖作为吸入剂载体的应用
|
KR102321339B1
(ko)
|
2013-07-18 |
2021-11-02 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
CN107106641B
(zh)
|
2014-10-31 |
2021-12-21 |
葛兰素史密斯克莱知识产权发展有限公司 |
粉末制剂
|